Skip to main content
SpringerLink
Log in

Antineoplastics

Febrile-neutropenia and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Salah S, et al. The O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and clinical outcomes of Ewing sarcoma patients treated with irinotecan and temozolomide. Reports of Practical Oncology and Radiotherapy 27 : 759-767, No. 5, Jan 2022. Available from: URL: http://doi.org/10.5603/rpOr.a2022.0084

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1966, 50 (2023). https://doi.org/10.1007/s40278-023-43503-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-43503-3

Search

Navigation